| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 10/01/1992 | CA2083060A1 Process for the extraction of peat and apparatus for carrying out the process |
| 09/30/1992 | EP0506124A1 Methods and substances for recruiting therapeutic agents to solid issues comprising two single chain VH-VL bifunctional binding molecules |
| 09/30/1992 | EP0505941A2 Peptifluorin and neopeptifluorin |
| 09/30/1992 | EP0505817A1 Use of phosphatidylserine and its derivatives for the manufacture of a medicament for the treatment of degenerative pathologies also associated with immune disfunctions |
| 09/30/1992 | EP0505552A1 Megakaryocyte maturation factors |
| 09/30/1992 | CN1064888A Mixed fermentation brewing technology using edible mushroom and chinese herbal medicine |
| 09/30/1992 | CN1064812A Method for manufacturing external medicine and health medicine using "organic shale" |
| 09/29/1992 | US5151499 Virus deactivated protein from plasma |
| 09/29/1992 | US5151268 DNA cloning vectors for genetic engineering |
| 09/29/1992 | CA2061476A1 Peptifluorin and neopeptifluorin |
| 09/29/1992 | CA1308086C Method and device for the separation and isolation of blood or bone marrow components |
| 09/29/1992 | CA1308033C Injectable soft tissue augmentation materials from the placenta and their method of manufacture |
| 09/26/1992 | WO1992016165A1 Artificial pancreatic perfusion device with temperature sensitive matrix |
| 09/26/1992 | CA2107123A1 Artificial pancreatic perfusion device with temperature sensitive matrix |
| 09/24/1992 | DE4129874C1 Granulating humic acids and/or cpds. - by mixing with granulating fluid for wet or moist granulation, then pressing through matrix |
| 09/23/1992 | EP0504191A1 Method and composition for the treatment of mammalian hiv infection. |
| 09/23/1992 | EP0227809B1 Process and composition for treatment of cancer and non-malignant tumors |
| 09/22/1992 | US5149718 Biological fluid purification system |
| 09/22/1992 | US5149653 By freeze-drying or drying in presence of stabilizer trehalose storage stability; used as immunogenic vaccines |
| 09/22/1992 | US5149543 Ionically cross-linked polymeric microcapsules |
| 09/22/1992 | US5149535 Fermentation with lactic acid bacteria |
| 09/22/1992 | US5149527 Administering to induce production of macrophages specifically cytotoxic for tumor cells |
| 09/22/1992 | CA1307753C Dna sequences, recombinant dna molecules and processes for producing mullerian inhibiting substance-like polypeptides |
| 09/19/1992 | CA2736076A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor |
| 09/17/1992 | WO1992015606A1 New inhibitors of endothelial cell proliferation |
| 09/17/1992 | WO1992015324A1 Preparation of factor ix |
| 09/17/1992 | WO1992015323A1 Protein-induced morphogenesis |
| 09/17/1992 | WO1992015322A1 Redirection of cellular immunity by receptor chimeras |
| 09/17/1992 | WO1992015292A1 Therapeutic compositions to protect and resuscitate mammalian cells and methods for preparing and using same |
| 09/16/1992 | EP0503991A1 Process for preparing a highly purified standardized concentrate of human von Willebrand factor on industrial scale, appropriate for therapeutic use |
| 09/16/1992 | EP0503959A1 Feed and feed additive for livestock, poultry and fish for increasing disease, pseudorabies resistance |
| 09/16/1992 | EP0503829A2 Hirudin for the inhibition of cancer metastasis |
| 09/16/1992 | EP0503682A1 Device for plasma modification composition and remodeling |
| 09/16/1992 | EP0502949A1 Homologous guluronic acid alginate coating composition for in-vivo application and implantation and method of using same |
| 09/16/1992 | CN1064504A Method for producing kanglemycin c |
| 09/16/1992 | CA2063039A1 Use of phosphatidylserine and its derivatives in degenerative pathologies also associated with immune disfunctions |
| 09/15/1992 | US5147803 Using (di- or tri)peptides |
| 09/15/1992 | US5147799 Repopulation of macrophages and granulocytes using transforming growth factor-beta |
| 09/15/1992 | US5147790 Tissue plasminogen activator, biosynthesis |
| 09/15/1992 | US5147782 Protease inhibitor, buffer, chelate compound |
| 09/15/1992 | US5147548 Colostrum filtered sterile |
| 09/15/1992 | US5147290 Method and machine based on the principle of centrifugation for cytapheresis such as platelet apheresis, and for plasma exchange treatment |
| 09/15/1992 | US5147289 Non-specific immune system enhancement |
| 09/10/1992 | DE4107122A1 Compsn. retarding skin ageing process - contains royal jelly, corn oil, chestnut flour and stinging nettles |
| 09/09/1992 | EP0502766A1 Dietary compositions based on phosphorylated lipids and their use to improve vision troubles |
| 09/09/1992 | EP0502765A1 New dietary compositions based on phosphorylated lipid complexes and their use in sleeping disorders |
| 09/09/1992 | EP0502213A1 Leukocyte removal method and leukocyte removal filter system |
| 09/09/1992 | EP0502172A1 Biomaterial based on collagen and its applications. |
| 09/09/1992 | EP0305400B1 A composition having reduced nephrotoxicity comprising a fatty acid containing component and cyclosporine |
| 09/09/1992 | CN1064214A Preparation method for hemorrhoidal powder |
| 09/09/1992 | CA2062388A1 Method and preparation for the inhibition or prevention of cancer metastasis |
| 09/08/1992 | CA1307256C Bbm-1675c and d antitumor antibiotics |
| 09/08/1992 | CA1307255C Process for producing a huminate fraction |
| 09/08/1992 | CA1307221C Brain-derived growth factor |
| 09/03/1992 | WO1992014485A1 A method for the diagnosis and treatment of glutamic acid decarboxylase autoantigen associated diseases |
| 09/03/1992 | WO1992014477A1 Method of treating systemic lupus erythematosus |
| 09/03/1992 | WO1992014476A1 Method of treating pulmonary inflammation |
| 09/03/1992 | WO1992014475A1 Prophylactic ferments for combatting dental caries |
| 09/03/1992 | DE4106570A1 Neue inhibitoren der endothelzell-proliferation New inhibitors of endothelial cell proliferation- |
| 09/03/1992 | CA2103568A1 Method of treating systemic lupus erythematosus |
| 09/02/1992 | WO1992015276A2 Therapeutic and cosmetic compositions for treatment of skin |
| 09/02/1992 | EP0501821A2 Anti-thrombin polypeptides |
| 09/02/1992 | EP0501445A1 Pharmaceutical composition comprising interleukin-2 |
| 09/02/1992 | EP0501399A1 Physiologically active kanglemycin C, process for preparing the same and use thereof |
| 09/02/1992 | EP0501354A1 Anticataract composition |
| 09/02/1992 | EP0500993A1 Hair protection film for cold permanent wave treatment |
| 09/02/1992 | EP0500893A1 Preservation of blood, tissues and biological fluids |
| 09/02/1992 | CN1064020A Electrothermal magnetotherapic medicine bag for stopping pain |
| 09/02/1992 | CN1064015A Method to process mole crickets used as an anticancer, antiphthisic medicine and nutriment |
| 09/02/1992 | CA2105313A1 Therapeutic and cosmetic compositions for treatment of skin |
| 09/02/1992 | CA2061642A1 Physiologically active kanglemycin c, process for preparing the same and use thereof |
| 09/01/1992 | US5143906 Kedarcidin antitumor chromophore and pharmaceutical composition containing same |
| 09/01/1992 | US5143845 Mixture of saccarifying lactic acid producing and butyric acid producing bacteria |
| 09/01/1992 | US5143727 Method for preventing diarrhea |
| 09/01/1992 | CA1306966C Human monocytes cultured in suspension in serum-free medium |
| 09/01/1992 | CA1306943C Blood products for parenteral administration |
| 09/01/1992 | CA1306930C Test carrier and process for the determination of coagulation parameters |
| 08/29/1992 | CA2061920A1 Anti-thrombin polypeptides |
| 08/28/1992 | CA2061918A1 Pharmaceutical compositions comprising a lymphokine |
| 08/28/1992 | CA2061133A1 Anticataract composition |
| 08/27/1992 | DE4105570A1 Verwendung eines bakterien- und eiweissfreien filtrats Use of a protein-free filtrate of bacteria and |
| 08/26/1992 | EP0500472A2 Leukocyte-removing filter and leukocyte-removing apparatus furnished therewith |
| 08/26/1992 | EP0288467B1 Stabilization of leukocytes |
| 08/25/1992 | US5141856 Expression of purified ciliary neurotrophic factor |
| 08/25/1992 | CA1306679C Use of polyvinylpyrrolidone (pvp) to reduce the turbidity of sera, sera containing pvp, and a process for the preparation thereof |
| 08/25/1992 | CA1306678C Active specific immune suppression |
| 08/23/1992 | WO1992014478A1 Process for producing a medical composition with a bone marrow protective effect and an anti-neoplastic effect |
| 08/23/1992 | CA2101645A1 Process for the production of a pharmaceutical preparation for producing a protective effect on bone marrow and an antineoplastic effect |
| 08/20/1992 | WO1992013875A1 Improved blood substitute |
| 08/20/1992 | WO1992013543A1 Method for extracting a biological substance from lepidoptera larvas and substance thus obtained |
| 08/19/1992 | EP0498871A1 Antimicrobial preservation of plasma |
| 08/19/1992 | EP0315627B1 A method to treat blood |
| 08/18/1992 | US5139792 Method and system for dispensing live bacteria into animal feed and drinking water |
| 08/18/1992 | US5139778 Antibiotic ge 2270 factors a1, a2, a3 and h |
| 08/18/1992 | US5139481 Treatment for type II diabetes |
| 08/18/1992 | CA1306416C Stimulation of hair growth |
| 08/16/1992 | WO1992014488A1 Structural gene of pneumococcal protein |
| 08/12/1992 | EP0497929A1 Composition for stabilizing blood plasma during pasteurization. |
| 08/12/1992 | EP0497922A1 Infective protein delivery system |
| 08/12/1992 | EP0497771A1 Dithiochrome, an insulin-binding molecule with glucose metabolism-related pharmaceutical utility |